Ramon Martin Chavez's Insider Trades & SAST Disclosures
Ramon Martin Chavez's most recent trade in Alphabet Inc - Ordinary Shares - Class A was a trade of 4 Class C Google Stock Units done . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ramon Martin Chavez.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 4 | 3,140 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 2 | 1,666 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 2 | 1,634 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 4 | 3,689 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 2 | 1,754 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 2 | 1,841 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 5 | 4,239 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 3 | 2,018 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 2 | 1,874 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 1,953 | 1,953 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 5 | 4,785 (0%) | 0% | 0 | Class C Google Stock Units | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 2 | 2,192 (0%) | 0% | 0 | Class C Google Stock Units | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 2,001 | 60,078 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Martin Chavez Ramon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 1,900 | 58,077 | - | 0 | Class A Common Stock | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 2,841 | 2,841 (0%) | 0% | 0 | Class C Google Stock Units | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 2,541 | 53,558 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 25,224 | 25,224 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 12,612 | 51,017 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 2,721 | 38,405 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 2,483 | 35,684 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 1,725 | 33,201 | - | 0 | Class A Common Stock | |
| Alphabet Inc - Ordinary Sh... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 8,824 | 8,824 (0%) | 0% | 0 | Class C Google Stock Units | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 2,224 | 31,476 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 36,290 | 36,290 | - | - | Stock Option (right to buy) | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 18,145 | 29,252 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 2,438 | 11,107 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,040 | 8,669 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 858 | 7,629 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 521 | 6,771 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | 20 Apr 2021 | 525,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | 20 Apr 2021 | 525,000 | 525,000 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | 20 Apr 2021 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | 20 Apr 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | ||
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | 20 Apr 2021 | 6,250 | 6,250 | - | - | Class A Common Stock | ||
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | 20 Apr 2021 | 6,250 | 0 | - | - | Common Stock | ||
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Ramon Martin Chavez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 6,250 | 6,250 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges